Trial Profile
Continuous Erector Spinae Block Versus Continuous Paravertebral Block Following Thoracotomy: A Randomized, Controlled Non-Inferiority Study
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Feb 2024
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 30 Jan 2024 Planned primary completion date changed from 31 Dec 2023 to 1 Dec 2024.
- 07 Feb 2023 Planned End Date changed from 1 Jul 2023 to 1 Dec 2024.
- 07 Feb 2023 Planned primary completion date changed from 1 Jan 2023 to 31 Dec 2023.